PMCTPharmaCountry
    Inicio

Actualizaciones regulatorias

Novedades regulatorias de FDA, EMA, TGA y organismos globales

#clinical safety ×

UPDATED
Actualizaciones regulatorias
30 ago 2026•1 min de lectura
FDA scientists caution against easing peptide drug regulations for compounding pharmacies
FDA internal scientists advise against loosening controls on seven peptide ingredients intended for ulcerative colitis, insomnia and obesity, citing insufficient safety data.